Kim Robert Young — SEC Form 4 filings

SEC reporting owner CIK 1971608. 2 Form 4 filings on record with FilingPulse; latest filed 2025-03-10.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2024-02-07 to 2025-03-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
4D Molecular Therapeutics, Inc. (FDMT)Chief Medical Officer24 legs · 24,552 sh · $737,7887

Form 4 filings — Kim Robert Young

FiledFormIssuerReported transactionsSource
2025-03-1044D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 92,300 (derivative) @ $0EDGAR
2024-02-0744D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 12,000 @ $18.66 · Sale (S): 12,000 @ $30.05 · Option exercise (M): 6,000 @ $15.78 · Sale (S): 6,000 @ $30.05 · Option exercise (M): 6,000 @ $8.04 · Sale (S): 6,000 @ $30.05 · +4 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1971608 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →